ten23 health AG

ten23 health AG Contract Manufacturing & Development (CDMO) Profile

ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. We support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. We are located in Switzerland, with three facilities: one in Basel and two in Visp. Find out more about us here: www.ten23.health

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs) Cartridges; Liquids; Lyophilized amps/vials; Pre-Filled Syringes (PFS); Sterile Vials Analytical Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development

Year Founded: 2021

Head Office: Basel, Switzerland

Number of Facilities: 1-2

Facility locations: Europe

Website: Visit the ten23 health AG website

Linkedin: Connect on Linkedin

Current Capacity: We have capacity for new business. 2 new lines opening in 2025.

Filling capabilities:

• Isolator line in class C, fully automated, individual container fill

• From 1 Liter to 500 Liter bulk compounding volume

• Batch sizes up to 20,000 units (Line 1) and 150,000 units (Line 2 and 3)

• Low to high viscosity (+ 1,000 cP)

• Precise and ultra-low volume filling, e.g. fill volume as low as 100μL at 5% precision for intravitreal applications

• Bubble-free filling & precise plunger setting (vacuum filling & stoppering capability)

• 100% IPC for fill weight check

Container Formats

• Vials (2R-30R), syringes (0.5 – 5mL) and cartridges (1.5-20mL)

• Ability to fill glass and polymer primary packaging

• Expertise in implementation & filling of innovative container solutions